Extracorporeal systemic hyperthermia and cis-diamminedichloroplatinum for treatment of patients with advanced cancer
Yokoyama, M.; Wada, J.; Nagara, H.; Kasagi, Y.; Itaoka, T.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(7): 1457-1461
1984
ISSN/ISBN: 0385-0684 PMID: 6540070 Document Number: 229701
Extracorporeal systemic hyperthermia was effective in removing pleural effusion or ascites and for pain relief in patients with advanced cancer. The administration of cisplatin was combined with hyperthermia. Partial remission was noted in 18% of the cases. With the use of cisplatin dosage over 1 mg/kg, approximately 50% of cases showed effective results. Cisplatin dosage should be 1.6mg/kg or more when combined with hyperthermia. Renal failure was the most common complication.
Document emailed within 1 workday
Related Documents
Takeda, T.; Nakamura, K.; Sato, M.; Takeda, T.; Tomimaru, Y.; Takeda, H. 2014: The effect of immunotherapy and hyperthermia on patients with advanced or recurrent cancer - analyses by cancer type and recurrence form Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(10): 1261-1263Iemwananonthachai, N.; Pattaranutaporn, P.; Chansilpa, Y.; Sukkasem, M. 2003: Hyperthermia in combination with radiation therapy for treatment of advanced inoperable breast cancer Journal of the Medical Association of Thailand 86(8): 715-721
Nakajima, K.; Hisazumi, H.; Nakashima, T.; Yokoyama, O.; Nagano, K.; Kobashi, K.; Naito, K.; Misaki, T.; Saito, Y.; Takashima, T. 1987: A combined treatment of interferon-alpha, 8 MHz radiofrequency hyperthermia and/or irradiation in a patient with advanced renal cancer Hinyokika Kiyo. Acta Urologica Japonica 33(11): 1851-1856
Okumura, S.; Hasegawa, J.; Ohhara, M.; Kawamura, N.; Abe, H.; Yui, Y.; Kanamori, S.; Yoshida, K.; Nishimura, T.; Tomita, M. 1984: Treatment of advanced prostatic carcinoma with cis-diamminedichloroplatinum Hinyokika Kiyo. Acta Urologica Japonica 30(12): 1801-1807
Ozeki, H.; Ogawa, M.; Horikoshi, N.; Inoue, K.; Mukaiyama, T.; Nagamine, D.; Ito, Y.; Imajo, K.; Shinagawa, K. 1988: Combination chemotherapy of 5-fluorouracil (5-FU), adriamycin (ADM), cis-diamminedichloroplatinum (II) (CDDP) and mitomycin C (MMC) (FAP.MMC) in advanced gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(1): 91-95
Lawson, D.; Moore, M.; Smalley, R. 1980: An evaluation of hexamethylmelamine, cis-diamminedichloroplatinum, and mitomycin-C in advanced breast cancer. a pilot study of the Southeastern Cancer Study Group Cancer Clinical Trials 3(4): 293-296
Grem, J.L. 2001: Biochemical modulation of 5-FU in systemic treatment of advanced colorectal cancer Oncology 15(1 Suppl 2: 13-19
Iwasaki, Y.; Ohashi, M.; Nunobe, S.; Iwanaga, T.; Iwagami, S.; Takahashi, K.; Yamaguchi, T.; Matsumoto, H.; Nakano, D. 2008: Treatment for advanced gastric cancer with positive lavage cytology-systemic versus intraperitoneal chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(12): 2009-2011
Wondergem, J.; Bulger, R.E.; Strebel, F.R.; Newman, R.A.; Travis, E.L.; Stephens, L.C.; Bull, J.M. 1988: Effect of cis-diamminedichloroplatinum(II) combined with whole body hyperthermia on renal injury Cancer Research 48(2): 440-446
Ben-Yosef, R. 2002: Hyperthermia combined with radiation therapy in the treatment of cancer patients Harefuah 141(5): 418
Kurpeshev, O.K.; Ragulin, Y.A.; Mozerov, S.A.; Orlova, A.V.; Lebedeva, T.V. 2016: Possibilities of local hyperthermia in treatment for edematous breast cancer patients Voprosy Onkologii 62(5): 680-687
Zamurovic, M.; Jurisic, A.; Andjelic, S. 2010: Systemic chemotherapy--before or after radical surgery in treatment of patients with advanced ovarian carcinoma? European Journal of Gynaecological Oncology 31(5): 564-566
Valente, R.; Marini, F.; Signori, G.B.; Martino, F. 1989: Quality of life in patients with advanced bladder cancer treated by tumorectomy and systemic adjuvant polychemotherapy (M-VAC). our experience in 14 cases Archivos Espanoles de Urologia 42(1): 87-89
Robins, H.I.; Sielaff, K.M.; Storer, B.; Hawkins, M.J.; Borden, E.C. 1989: Phase I trial of human lymphoblastoid interferon with whole body hyperthermia in advanced cancer Cancer Research 49(6): 1609-1615
Wada, T.; Kunisaki, C.; Hasegawa, S.; Kaida, S.; Tamura, S.; Ono, H.; Oshima, T.; Fujii, S.; Kosaka, T.; Makino, H.; Akiyama, H.; Endo, I. 2013: A case of locally advanced gastric cancer in which the patient underwent curative gastrectomy after treatment with systemic chemotherapy with bi-weekly s-1/docetaxel Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(11): 1533-1536
Von Ardenne, M.; Reitnauer, P.G. 1971: In vitro study for shortening of hyperthermia duration in multi-step cancer therapy. Release of lysosomal cytolysis chain reaction by over-acidification and hyperthermia and its continuation after cessation of hyperthermia Archiv für Geschwulstforschung 38(3): 264-269
Herman, T.S.; Teicher, B.A.; Holden, S.A.; Pfeffer, M.R.; Jones, S.M. 1990: Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma Cancer Research 50(9): 2734-2740
Yamamoto, C.; Yamamoto, D.; Tsubota, Y.; Sueoka, N.; Kawakami, K.; Yamamoto, M. 2014: The synergistic effect of local microwave hyperthermia and chemotherapy for advanced or recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(12): 1921-1923
Sugiyama, Y.; Suzuki, H.; Hada, R.; Miyagishima, K.; Yokoyama, M.; Daidouji, K.; Murata, A.; Yamazaki, S.; Mikami, Y.; Ozawa, M. 1991: Total body hyperthermia and continuous hyperthermic peritoneal perfusion as an adjuvant therapy in advanced gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(4): 619-624
Solheim, O. 1973: Treatment of patients with advanced cancer Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 93(26): 1867-1871